88 results
Page 3 of 5
8-K
EX-99.1
106camf8aqnh2s
3 Feb 21
Regulation FD Disclosure
12:00am
8-K
EX-99.1
qr4e6
2 Nov 20
Rhythm Pharmaceuticals Reports Third Quarter 2020 Financial Results
9:32am
8-K
EX-99.1
iydeni7
3 Aug 20
Rhythm Pharmaceuticals Reports Second Quarter 2020 Financial Results
9:25am
8-K
EX-99.1
dbxr naq8wbo68z50ua
10 Jan 20
Regulation FD Disclosure
8:46am
8-K
EX-99.1
q12sdznx0mce9hrl0k
6 Nov 19
Rhythm Pharmaceuticals Announces Late-breaking Data from Phase 3 Trials of Setmelanotide in POMC and LEPR Deficiency Obesities at ObesityWeek 2019
9:28am
8-K
EX-1.1
avaej6 9s
16 Oct 19
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering
5:27pm
424B5
hs1cjw
16 Oct 19
Prospectus supplement for primary offering
5:25pm
424B5
cape6vig
15 Oct 19
Prospectus supplement for primary offering
4:51pm
8-K
EX-99.1
q7tckuekfbt1 r8e14u8
7 Aug 19
Other Events
9:07am
8-K
EX-99.2
cwxfmmz cb
7 Aug 19
Other Events
9:07am
8-K
EX-99.1
nvj17bzna tphts0
29 Jul 19
Regulation FD Disclosure
4:40pm
8-K
EX-99.1
wu02jnbkv6l53tu3jghr
29 Jul 19
Rhythm Pharmaceuticals Reports Second Quarter 2019 Financial Results
4:40pm
8-K
EX-99.1
gtj5u22 he8vczr80
25 Jul 19
Rhythm Pharmaceuticals Announces Appointment of Stuart Arbuckle to its Board of Directors
4:01pm